Literature DB >> 34340772

An integrative analysis to distinguish between emphysema (EML) and alpha-1 antitrypsin deficiency-related emphysema (ADL)-A systems biology approach.

S Udhaya Kumar1, N Madhana Priya2, D Thirumal Kumar3, V Anu Preethi4, Vibhaa Kumar1, Dhanushya Nagarajan1, R Magesh2, Salma Younes5, Hatem Zayed5, C George Priya Doss6.   

Abstract

Lung Emphysema is an abnormal enlargement of the air sacs followed by the destruction of alveolar walls without any prominent fibrosis. This study primarily identifies the differentially expressed genes (DEGs), interactions between them, and their significant involvement in the activated signaling cascades. The dataset with ID GSE1122 (five normal lung tissue samples, five of usual emphysema, and five of alpha-1 antitrypsin deficiency-related emphysema) from the gene expression omnibus (GEO) was analyzed using the GEO2R tool. The physical association between the DEGs were mapped using the STRING tool and was visualized in the Cytoscape software. The enriched functional processes were identified with the ClueGO plugin's help from Cytoscape. Further integrative functional annotation was performed by implying the GeneGo Metacore™ to distinguish the enriched pathway maps, process networks, and GO processes. The results from this analysis revealed the critical signaling cascades that have been either activated or inhibited due to identified DEGs. We found the activated pathways such as immune response IL-1 signaling pathway, positive regulation of smooth muscle migration, BMP signaling pathway, positive regulation of leukocyte migration, NIK/NF-kappB signaling, and cytochrome-c oxidase activity. Finally, we mapped four crucial genes (CCL5, ALK, TAC1, CD74, and HLA-DOA) by comparing the functional annotations that could be significantly influential in emphysema molecular pathogenesis. Our study provides insights into the pathogenesis of emphysema and helps in developing potential drug targets against emphysema.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-1 antitrypsin deficiency; COPD; ClueGO; Functional enrichment analysis; Genogo; Lung emphysema; Protein-protein interaction

Year:  2021        PMID: 34340772     DOI: 10.1016/bs.apcsb.2021.02.004

Source DB:  PubMed          Journal:  Adv Protein Chem Struct Biol        ISSN: 1876-1623            Impact factor:   3.507


  7 in total

1.  Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction.

Authors:  Ming Shen; Rui Gong; Haibin Li; Zhihui Yang; Yunpeng Wang; Dandan Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.

Authors:  Ningning Wang; Haichen Zhang; Dan Li; Chunteng Jiang; Haidong Zhao; Yun Teng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Development and Validation of Ten-RNA Binding Protein Signature Predicts Overall Survival in Osteosarcoma.

Authors:  Jian Zhang; Xinxin Miao; Tianlong Wu; Jingyu Jia; Xigao Cheng
Journal:  Front Mol Biosci       Date:  2021-12-01

4.  Bio-informatics and in Vitro Experiments Reveal the Mechanism of Schisandrin A Against MDA-MB-231 cells.

Authors:  Ling Chen; Li-Quan Ren; Zhong Liu; Xin Liu; Han Tu; Xu-Ying Huang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Long non-coding RNAs PGM5-AS1 upregulates Decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284.

Authors:  Huimin Wang; Dan Wang; Qiong Wei; Chun Li; Chunyan Li; Jing Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis.

Authors:  Jing Yang; Yi Zhou; Yanchun Li; Wanye Hu; Chen Yuan; Shida Chen; Gaoqi Ye; Yuzhou Chen; Yunyi Wu; Jing Liu; Ying Wang; Jing Du; Xiangmin Tong
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of BanXia-YiYiRen in treating insomnia.

Authors:  Liang Wang; Peng Wang; Yingfan Chen; Chen Li; Xuelin Wang; Yin Zhang; Shaodan Li; Minghui Yang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.